Ignite Creation Date:
2024-05-06 @ 7:56 PM
Last Modification Date:
2024-10-26 @ 3:17 PM
Study NCT ID:
NCT06191978
Status:
RECRUITING
Last Update Posted:
2024-07-08
First Post:
2023-12-19
Brief Title:
A Phase IaIb Open-label Multiple Dose Study to Determine the Recommended Dose Evaluate PKs PDs Safety and Activity of Venetoclax in Combination With Oral DecitabineCedazuridine ASTX727 in Pediatric Patients With RelapsedRefractory Acute Myeloid Leukemia AML
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-07
Start Date Type:
ACTUAL
Primary Completion Date:
2028-12-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-12-31
Completion Date Type:
ESTIMATED
First Submit Date:
2023-12-19
First Submit QC Date:
December 20 2023
Study First Post Date:
2024-01-05
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-19
Last Update Post Date:
2024-07-08
Last Update Post Date Type:
ACTUAL